Press-release for stocks published on yesterday

Prices are updated after-hours

published : Yesterday source : Www.biospace.com

save search

Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-18 (Crawled : 00:00) - biospace.com/
QSI | $1.52 -0.65% -0.66% 770K

Professional, Scientific, and T...

| -0.65% | O: -0.65% H: 0.0% C: 0.0%
first report financial results

Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Published: 2024-04-18 (Crawled : 00:00) - biospace.com/
EVH | $29.62 -0.07% 0.0% 830K

Commercial Services

| -1.53% | O: -1.53% H: 0.0% C: 0.0%
first financial results

U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M

Health Technology

| 0.08% | O: 0.08% H: 0.46% C: 0.0%
entyvio fda disease active for therapy

Windtree Therapeutics Announces Reverse Stock Split - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
WINT | News | $0.3399 -15.3% -18.06% 1.8M

Health Technology

| -30.25% | O: -30.25% H: 0.0% C: 0.0%
therapeutics

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
SDGR | News | $24.37 -2.68% -2.75% 670K

Technology Services

| 0.38% | O: 0.38% H: 0.0% C: 0.0%
nasdaq grants

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
MBRX | News | $4.59 7.24% 6.75% 50K

Health Technology

| 5.61% | O: 4.91% H: 11.36% C: 0.67%
drug treatment designation for grants leukemia

Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M

Health Technology

| -0.04% | O: -0.04% H: 0.0% C: 0.0%
gilead report sciences impact esg

Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ALNY | News | $145.045 -0.19% -0.19% 400K

Health Technology

| -1.06% | O: -1.17% H: 1.01% C: 0.11%
first conference financial results

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024Conference call scheduled for 4:30 p.m. Eastern Time
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ARDX | News | $6.445 -1.6% -1.63% 3.5M

Health Technology

| -4.31% | O: -2.97% H: 0.61% C: -1.38%
first report for financial results

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
VRTX | News | $393.51 0.1% 0.1% 950K

Health Technology

| 0.47% | O: 0.47% H: 0.0% C: 0.0%
vx-548

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
PSTX | News | $2.005 -1.72% -1.75% 520K

Health Technology

| 0.25% | O: 0.25% H: 0.0% C: 0.0%
cell meeting therapeutics therapy

Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
IMMX | News | $2.25 -10.0% -11.11% 190K

| -3.6% | O: -3.6% H: 0.0% C: 0.0%
nxc-201 biopharma

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
TWST | News | $28.345 -0.79% -0.79% 810K

Health Technology

| -0.04% | O: -0.04% H: 0.0% C: 0.0%
report bioscience financial results

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
YS | News | $0.87 -7.05% -7.59% 350K

n/a

| -7.45% | O: -7.45% H: 0.0% C: 0.0%
hepatitis vaccine license granted biopharma virus trial

Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
COYA | News | $8.53 3.52% 3.4% 30K

| -1.1% | O: -1.1% H: 0.0% C: 0.0%
drug als therapeutics development

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ANIX | News | $3.09 1.31% 1.29% 59K

Health Technology

| -1.89% | O: -1.89% H: 0.0% C: 0.0%
business cancer

Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene Therapy, for Advancing AI-Driven Therapies
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
FDMT | News | $24.71 -2.33% -2.39% 420K

Health Technology

| -1.23% | O: -1.23% H: 0.0% C: 0.0%
cell for

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
CERS | News | $1.645 0.31% 0.3% 760K

Health Technology

| -2.38% | O: -2.38% H: 4.27% C: 0.0%
first corporation financial results

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
BIO | News | $281.02 -3.38% -0.36% 370K

Health Technology